The drug is available in a 500-mg capsulefor oral use. Hydroxyurea is often considered an antimetabolitedrug, and it is used to treat myelogenousleukemia, ovarian cancer, and essential thrombocytosis. Themechan
Hydroxyurea 活性组分 Hydroxyurea 商标名 Hydroxyurea 申请人 Barr 剂型及给药途径 Capsule; Oral 剂量 500mg 申请类型 A NDA 075143 产品号 001 批准日 1998-10-16 RLD标识 No 类型 RX 申请人全称 Barr Laboratories Inc 关于我们|会员服务|至尊标王|广告服务|联系我们|法律声明|隐私条款|服务协...
001 HYDROXYUREA HYDROXYUREA CAPSULE;ORAL 500MG No No AB 1999/02/24 1999/02/24 Prescription批准日期,申请提交历史,通知信,药品说明书,审评文件等信息 >>>原始批准或临时批准<<< 审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注 1999/02/24 ORIG-1(原始申请)...
Hydroxyurea - Detailed Prescribing InformationDrugs
The PK profiles of hydroxyurea after administration of the capsule and liquid formulations were essentially bioequivalent and interchangeable (supplemental Table 1, available on the Blood Web site; see the Supplemental Materials link at the top of the online article), and results from both ...
HYDROXYUREA CAPSULES, USPRx onlyDescriptionHydroxyurea Capsules, USP is an antineoplastic agent, occurs as an essentially tasteless, white crystalline powder. Its structural formula is:CH4N2O2 Molecular Weight: 76.06 Each capsule, for oral administration contains 500 mg hydroxyurea. In addition, each cap...
Dosage forms: oral capsule (200 mg; 300 mg; 400 mg; 500 mg), oral tablet (100 mg; 1000 mg) Drug class: AntimetabolitesMedically reviewed by Drugs.com on Aug 9, 2023. Written by Cerner Multum.Uses Side effects Warnings Before taking Dosage Interactions What...
HONH-CO-NH2. The drug is available in a 500-mg capsulefor oral use. Hydroxyurea is often considered an antimetabolitedrug, and it is used to treat myelogenousleukemia, ovarian cancer, and essential thrombocytosis. Themechanism of action of hydroxyurea involves inhibition ofDNA biosynthesis by inhi...
>>>活性成分:HYDROXYUREA;剂型/给药途径:CAPSULE;ORAL;规格:500MG;治疗等效代码:AB<<< 申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人 016295001NDAHYDREAHYDROXYUREACAPSULE;ORAL500MGPrescriptionYesYesABApproved Prior to Jan 1, 1982CHEPLAPHARM ...
Sickle cell disease (SCD) is a chronic hemolytic anemia affecting millions worldwide with acute and chronic clinical manifestations and early mortality. While hydroxyurea (HU) and other treatment strategies managed to ameliorate disease severity, high in